
MannKind Corp
NASDAQ:MNKD

MannKind Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.54
7.44
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does MannKind Corp hold over its rivals?
What risks and challenges
does MannKind Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of MannKind Corp.
Provide an overview of the primary business activities
of MannKind Corp.
What unique competitive advantages
does MannKind Corp hold over its rivals?
What risks and challenges
does MannKind Corp face in the near future?
Has there been any significant insider trading activity
in MannKind Corp recently?
Summarize the latest earnings call
of MannKind Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for MannKind Corp.
Provide P/S
for MannKind Corp.
Provide P/E
for MannKind Corp.
Provide P/OCF
for MannKind Corp.
Provide P/FCFE
for MannKind Corp.
Provide P/B
for MannKind Corp.
Provide EV/S
for MannKind Corp.
Provide EV/GP
for MannKind Corp.
Provide EV/EBITDA
for MannKind Corp.
Provide EV/EBIT
for MannKind Corp.
Provide EV/OCF
for MannKind Corp.
Provide EV/FCFF
for MannKind Corp.
Provide EV/IC
for MannKind Corp.
Show me price targets
for MannKind Corp made by professional analysts.
What are the Revenue projections
for MannKind Corp?
How accurate were the past Revenue estimates
for MannKind Corp?
What are the Net Income projections
for MannKind Corp?
How accurate were the past Net Income estimates
for MannKind Corp?
What are the EPS projections
for MannKind Corp?
How accurate were the past EPS estimates
for MannKind Corp?
What are the EBIT projections
for MannKind Corp?
How accurate were the past EBIT estimates
for MannKind Corp?
Compare the revenue forecasts
for MannKind Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of MannKind Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of MannKind Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of MannKind Corp compared to its peers.
Compare the P/E ratios
of MannKind Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing MannKind Corp with its peers.
Analyze the financial leverage
of MannKind Corp compared to its main competitors.
Show all profitability ratios
for MannKind Corp.
Provide ROE
for MannKind Corp.
Provide ROA
for MannKind Corp.
Provide ROIC
for MannKind Corp.
Provide ROCE
for MannKind Corp.
Provide Gross Margin
for MannKind Corp.
Provide Operating Margin
for MannKind Corp.
Provide Net Margin
for MannKind Corp.
Provide FCF Margin
for MannKind Corp.
Show all solvency ratios
for MannKind Corp.
Provide D/E Ratio
for MannKind Corp.
Provide D/A Ratio
for MannKind Corp.
Provide Interest Coverage Ratio
for MannKind Corp.
Provide Altman Z-Score Ratio
for MannKind Corp.
Provide Quick Ratio
for MannKind Corp.
Provide Current Ratio
for MannKind Corp.
Provide Cash Ratio
for MannKind Corp.
What is the historical Revenue growth
over the last 5 years for MannKind Corp?
What is the historical Net Income growth
over the last 5 years for MannKind Corp?
What is the current Free Cash Flow
of MannKind Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for MannKind Corp.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
MannKind Corp
NASDAQ:MNKD
|
1.2B USD | 14.8 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -194 789.6 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
336.1B USD | 15.4 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
325.9B USD | -13 213.5 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
164.8B USD | 14.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
144.7B USD | 10.5 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.8B USD | 26 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -580 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
129.7B AUD | 19 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
60.9B USD | 12.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -66.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
MannKind Corp
NASDAQ:MNKD
|
Average EV/EBITDA:
16.1
14.8
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -194 789.6 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
15.4
|
13%
|
1.2 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
Negative Multiple: -13 213.5 | N/A | N/A |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
14.8
|
17%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
10.5
|
6%
|
1.8 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
26
|
17%
|
1.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -580 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
19
|
11%
|
1.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
12.1
|
11%
|
1.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -66.5 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.